Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease — Daniela Corna (1997) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease
Shared by
Giuseppe Remuzzi
Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease
Article
1997
en
Authors
+3 more
DC
Daniela Corna
MM
Marina Morigi
DF
Daniela Facchinetti
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1998
Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease
Carla Zoja
,
Daniela Corna
,
Giuditta Benedetti
,
Marina Morigi
,
Roberta Donadelli
,
Angelo Guglielmotti
,
Mario Pinza
,
Tullio Bertani
,
Giuseppe Remuzzi
Article
2006
Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease
Carla Zoja
,
Daniela Corna
,
Daniela Rottoli
,
Cristina Zanchi
,
Mauro Abbate
,
Giuseppe Remuzzi
Article
2001
Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis
Carla Zoja
,
Ariela Benigni
,
Marina Noris
,
Daniela Corna
,
Federica Casiraghi
,
Marcella Pagnoncelli
,
Daniela Rottoli
,
Mauro Abbate
,
Giuseppe Remuzzi
Article
2007
Mycophenolate Mofetil versus Azathioprine for Prevention of Chronic Allograft Dysfunction in Renal Transplantation
Giuseppe Remuzzi
,
Paolo Cravedi
,
Marco Costantini
,
Mariadomenica Lesti
,
María Ganeva
,
Giulia Gherardi
,
Bogdan Ene‐Iordache
,
Eliana Gotti
,
Donato Donati
,
Maurizio Salvadori
,
Silvio Sandrini
,
Giuseppe Segoloni
,
Stefano Federico
,
Paolo Rigotti
,
Vito Sparacino
,
Piero Ruggenenti
Article
2016
Targeting Sirtuin-1 prolongs murine renal allograft survival and function
Matthew H. Levine
,
Zhong Lin Wang
,
Haiyan Xiao
,
Jing Jiao
,
Liqing Wang
,
Tricia R. Bhatti
,
Wayne W. Hancock
,
Ulf H. Beier
Discussion(0)
No comments yet. Be the first to comment.